Name	Value
Compound	Tofacitinib (CP-690.550)
Investigated event	Influence on protein activity in presence of TGF-β and IL-6
Experiment type	Western Blot
Concentration	100.00 nM
Cell line	Naïve CD4+ T
Organism	Mus musculus
Animal model	c57BL/6
STAT protein
Other	SMAD2

Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation. Biochemical and biophysical research communications Hideyuki Yoshida, Akihiro Kimura, Tomohiro Fukaya, Takashi Sekiya, Rimpei Morita, Takashi Shichita, Hiromasa Inoue, Akihiko Yoshimura, 418, 2, 2012-02-10, 2012-01-09, 10.1016/j.bbrc.2011.12.156 DOI: 10.1016/j.bbrc.2011.12.156 PUBMED: 22252297 PMCID: 22252297